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 Abstract 
Aminoacyl-tRNA synthetases (aaRSs) are essential enzymes present in all living 
organisms, their catalytic activity is involved in the translation of the genetic code into 
functional proteins and they are potential targets for anti-infective agents. The first step in 
the biosynthetic pathway catalysed by aaRSs consists of activation of the corresponding 
amino acid by the reaction with ATP to form an aminoacyl-adenylate (aa-AMP), the key 
intermediate in the biosynthesis of proteins. As a result stable, analogues of aa-AMP have 
been identified as potential and valuable lead compounds for the development of potential 
aaRS inhibitors. 
This thesis describes the design and synthesis of potential aaRSs inhibitors. The studies 
involve the development of a novel solution-phase synthetic route to non-hydrolysable 
sulfamoyl-based aa-AMP analogues. Synthesis includes the development of a protective 
group strategy that utilises global deprotection under neutral conditions to minimise by-
product formation. Optimal reaction conditions for the coupling of different amino acids 
to the sulfamoyl moiety have also been investigated. 
A solid-phase synthetic route leading to non-hydrolysable sulfamoyl-based aa-AMP 
analogues has also been developed. The novel synthetic route enables the possibility for 
rapid parallel synthesis of structurally diverse compounds in quantities sufficient for 
biological evaluation.  
Molecular modelling techniques have been used to gain understanding about the 
structure–activity relationship of the inhibitors of aaRSs based on non-hydrolysable aa-
AMP analogues. A model ligand adopting the putative bioactive conformation was 
identified based on X-ray data and conformational searches. Novel phosphate bioisosteres 
of aa-AMP have been designed using the derived model. 
Molecular docking techniques were used for the design of ribose-free purine-based aa-
AMP bioisosteres. The designed compounds were synthesised and evaluated biologically 
in an assay using aaRS isolated from Escherichia coli.  
A novel mild method for the activation and recycling of a tritylated solid-phase resin has 
also been developed. Recycling of recovered resin after the completion of a reaction is 
considered beneficial since it minimises the associated costs and is environmentally 
friendly. The method was used for the attachment of primary and secondary alcohols, 
halogen-containing alcohols and anilines to trityl resin.  
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